Critical Comparison: SCWorx (NASDAQ:WORX) and Augmedix (OTCMKTS:AUGX)

Augmedix (OTCMKTS:AUGX) and SCWorx (NASDAQ:WORX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, dividends, risk, profitability and institutional ownership.

Profitability

This table compares Augmedix and SCWorx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Augmedix	-57.70%	-980.09%	-57.85%
SCWorx	N/A	N/A	N/A

Risk & Volatility

Augmedix has a beta of -0.22, suggesting that its share price is 122% less volatile than the S&P 500. Comparatively, SCWorx has a beta of 2.44, suggesting that its share price is 144% more volatile than the S&P 500.

Institutional & Insider Ownership

87.1% of Augmedix shares are held by institutional investors. Comparatively, 1.9% of SCWorx shares are held by institutional investors. 11.0% of Augmedix shares are held by company insiders. Comparatively, 9.0% of SCWorx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Augmedix and SCWorx”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Augmedix	$51.58 million	2.23	-$24.45 million	($0.43)	-5.47
SCWorx	$3.62 million	0.37	-$3.98 million	($0.95)	-1.17

SCWorx has lower revenue, but higher earnings than Augmedix. Augmedix is trading at a lower price-to-earnings ratio than SCWorx, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings for Augmedix and SCWorx, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Augmedix	0	0	0	0	N/A
SCWorx	0	0	0	0	N/A

Summary

SCWorx beats Augmedix on 6 of the 11 factors compared between the two stocks.

About Augmedix

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

About SCWorx

SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. It also offers virtualized item master file repair, expansion, and automation; electronic medical record management; charge description master management; contract management; request for proposal automation; rebate management; integration of acquired management; big data analytics modeling; data integration and warehousing; and ScanWorx. In addition, the company focuses on selling personal protective equipment and COVID-19 rapid test kits. It sells its solutions and services to hospitals and health systems through its direct sales force, and distribution and reseller partnerships. SCWorx Corp. is based in New York, New York.